AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore
Biopharma companies at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
10 biopharma companies are at AMP 2026 — 4 presentations on the program and 8 with a booth in the exhibit hall. Most represented: AstraZeneca (1 on the program). 9 of them have their own page in this guide. As of Nov 12, 2026.
Program track
Top represented
Showing 1–10 of 10 organizations
| Organization | AMP 2026 Attendance |
|---|---|
AstraZeneca Cambridge, UK | |
Biopharmaceutical company developing prescription medicines in oncology; cardiovascular, renal and metabolism; and respiratory disease. | Booth Exhibiting at Booth 820 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Diamond Partner Workshop Wed, Nov 11 4:00pm–4:50pm From Manual to Automated Tissue Dissection: Real-World Experiences with the Tissector TT™ Laboratories describe swapping manual tissue dissection for an automated instrument, and what implementation took. |
Eli Lilly Indianapolis, IN | |
Pharmaceutical company discovering, developing and marketing medicines, and running clinical trials worldwide. | Booth Exhibiting at Booth 831, MR5 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm |
Johnson & Johnson New Brunswick, NJ | |
Johnson & Johnson Innovative Medicine develops medicines in oncology, immunology, neuroscience, cardiovascular disease, pulmonary hypertension and retina. | Booth Exhibiting at Booth 817, MR7 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Platinum Partner Workshop Wed, Nov 11 8:00am–8:50am The Precision Pathway: How Pathologists Are Transforming Biomarker Discovery, Selection, and Clinical Impact Across GU Cancers Biomarker selection, specimen handling and reporting for genitourinary cancers, worked through interactive case discussions. |
Merck & Co. Rahway, NJ | |
Pharmaceutical company developing oncology medicines, with a large clinical research program in cancer. | Booth Exhibiting at Booth 801, MR9 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Gold Partner |
AbbVie North Chicago, IL | |
Pharmaceutical company developing medicines across immunology, oncology, neuroscience, eye care and aesthetics. | Booth Exhibiting at Booth 908 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Gold Partner |
Amgen Thousand Oaks, CA | |
Independent biotechnology company developing and marketing medicines for serious illnesses. | Booth Exhibiting at Booth 1703 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Gold Partner |
Pfizer New York, NY | |
Pharmaceutical company; its oncology unit develops medicines for some of the world's most common cancers. | Booth Exhibiting at Booth 1023 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Gold Partner |
Revolution Medicines Redwood City, CA | |
Oncology company developing oral RAS(ON) inhibitors for patients with RAS-addicted cancers. | Booth Exhibiting at Booth 528 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 3:00pm–3:50pm RAS in ACTION - From A Single Mutation to a Targeted Class RAS mutation testing across lung, colorectal and pancreatic cancers, with tissue and liquid biopsy considerations for targeted therapy. Workshop Thu, Nov 12 4:25pm–4:55pm It's Hard to Treat What You Can't See: Leveraging Molecular Diagnostics to Improve Care of Patients with Pancreatic Lesions Pancreatic lesions are hard to call on imaging and cytology alone; molecular testing can sharpen diagnosis and risk stratification. |
Pharmaceutical company developing medicines in oncology, hematology, immunology and cardiovascular disease. | 🏅Gold Partner |
Eli Lilly's oncology research and development unit, developing targeted cancer medicines. | 🏅Gold Partner |
Find buyers from biopharma companies
Tell us what you sell and we’ll find the people at these biopharma companies most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse AMP 2026 by
Organization type
Program track
Exhibit hall
Everyone
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction